N-arachidonoyl glycine, another endogenous agonist of GPR55

Biochemical and Biophysical Research Communications

Volumn 490, Issue 4, 2017, Pages 1389-1393

  Console Bram, Linda ^a   Ciuciu, Sandra M ^a   Zhao, Pingwei ^a   Zipkin, Robert E ^b   Brailoiu, Eugen ^a   Abood, Mary E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Focus Biomolecules   (United States)

Author keywords

Calcium; GPR55; Inositol 3 phosphate receptor; Mitogen activated protein kinase; N arachidonyl glycine

Indexed keywords

AMINO ACID; CALCIUM; CALCIUM CHANNEL; CANNABINOID RECEPTOR AGONIST; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; GLYCINE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; ML 193; N ARACHIDONOYL GLYCINE; POLY DEXTRO LYSINE; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; GLYCINE; GPR55 PROTEIN, HUMAN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N-ARACHIDONYLGLYCINE; QUINOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CHO CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR CALCIUM; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CRICETULUS; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KINETICS; METABOLISM;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; CHO CELLS; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLYCINE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; QUINOLINES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85023209349     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.07.038     Document Type: Article

References (23)

1. Henstridge, C.M., Balenga, N.A., Kargl, J., Andradas, C., Brown, A.J., Irving, A., Sanchez, C., Waldhoer, M., Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. Mol. Endocrinol. 25 (2011), 1835–1848.
2. Hanus, L., Shohami, E., Bab, I., Mechoulam, R., N-Acyl amino acids and their impact on biological processes. Biofactors 40 (2014), 381–388.
3. Tan, B., Bradshaw, H.B., Rimmerman, N., Srinivasan, H., Yu, Y.W., Krey, J.F., Monn, M.F., Chen, J.S., Hu, S.S., Pickens, S.R., Walker, J.M., Targeted lipidomics: discovery of new fatty acyl amides. AAPS J. 8 (2006), E461–E465.
4. Tan, B., O'Dell, D.K., Yu, Y.W., Monn, M.F., Hughes, H.V., Burstein, S., Walker, J.M., Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J. lipid Res. 51 (2010), 112–119.
5. Zhang, X., Maor, Y., Wang, J.F., Kunos, G., Groopman, J.E., Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. Br. J. Pharmacol. 160 (2010), 1583–1594.
6. Console-Bram, L., Brailoiu, E., Brailoiu, G.C., Sharir, H., Abood, M.E., Activation of GPR18 by cannabinoid compounds: a tale of biased agonism. Br. J. Pharmacol. 171 (2014), 3908–3917.
7. McHugh, D., Hu, S.S., Rimmerman, N., Juknat, A., Vogel, Z., Walker, J.M., Bradshaw, H.B., N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci., 11, 2010, 44.
8. Finlay, D.B., Joseph, W.R., Grimsey, N.L., Glass, M., GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine. PeerJ, 4, 2016, e1835.
9. Lu, V.B., Puhl, H.L. 3rd, Ikeda, S.R., N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways. Mol. Pharmacol. 83 (2013), 267–282.
10. Heynen-Genel, S., Dahl, R., Shi, S., Milan, L., Hariharan, S., Sergienko, E., Hedrick, M., Dad, S., Stonich, D., Su, Y., Vicchiarelli, M., Mangravita-Novo, A., Smith, L.H., Chung, T.D.Y., Sharir, H., Caron, M.G., Barak, L.S., Abood, M.E., Screening for selective ligands for gpr55-antagonists, probe reports from the NIH molecular libraries program. Bethesda (MD), 2010 PMID: 22091481.
11. Brailoiu, G.C., Oprea, T.I., Zhao, P., Abood, M.E., Brailoiu, E., Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide. J. Biol. Chem. 286 (2011), 29166–29174.
12. Brailoiu, G.C., Deliu, E., Marcu, J., Hoffman, N.E., Console-Bram, L., Zhao, P., Madesh, M., Abood, M.E., Brailoiu, E., Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors. Biochemistry 53 (2014), 4990–4999.
13. Barr, J.L., Deliu, E., Brailoiu, G.C., Zhao, P., Yan, G., Abood, M.E., Unterwald, E.M., Brailoiu, E., Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways. Cell Calcium 58 (2015), 196–207.
14. Deliu, E., Sperow, M., Console-Bram, L., Carter, R.L., Tilley, D.G., Kalamarides, D.J., Kirby, L.G., Brailoiu, G.C., Brailoiu, E., Benamar, K., Abood, M.E., The lysophosphatidylinositol receptor GPR55 modulates pain perception in the periaqueductal gray. Mol. Pharmacol. 88 (2015), 265–272.
15. Grynkiewicz, G., Poenie, M., Tsien, R.Y., A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985), 3440–3450.
16. Gagliardi, S., Rees, M., Farina, C., Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase. Curr. Med. Chem. 6 (1999), 1197–1212.
17. Maruyama, T., Kanaji, T., Nakade, S., Kanno, T., Mikoshiba, K., 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. J. Biochem. 122 (1997), 498–505.
18. Xu, S.Z., Zeng, F., Boulay, G., Grimm, C., Harteneck, C., Beech, D.J., Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br. J. Pharmacol. 145 (2005), 405–414.
19. Gafni, J., Munsch, J.A., Lam, T.H., Catlin, M.C., Costa, L.G., Molinski, T.F., Pessah, I.N., Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 19 (1997), 723–733.
20. Huang, S.M., Bisogno, T., Petros, T.J., Chang, S.Y., Zavitsanos, P.A., Zipkin, R.E., Sivakumar, R., Coop, A., Maeda, D.Y., De Petrocellis, L., Burstein, S., Di Marzo, V., Walker, J.M., Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276 (2001), 42639–42644.
21. Takekura, H., Takeshima, H., Nishimura, S., Takahashi, M., Tanabe, T., Flockerzi, V., Hofmann, F., Franzini-Armstrong, C., Co-expression in CHO cells of two muscle proteins involved in excitation-contraction coupling. J. muscle Res. Cell Motil. 16 (1995), 465–480.
22. Henstridge, C.M., Balenga, N.A., Ford, L.A., Ross, R.A., Waldhoer, M., Irving, A.J., The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J. Official Publ. Fed. Am. Soc. Exp. Biol. 23 (2009), 183–193.
23. Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., Sugiura, T., Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem. Biophys. Res. Commun. 362 (2007), 928–934.